Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
SARS drug ready for clinical trial
Fri April 3rd - A drug developed to treat lung disease has shown early promise against the Covid-19 virus, researchers reported last night. More
'Promising' COVID-19 vaccine revealed
Fri April 3rd - A potential vaccine for COVID-19 has been described for the first time after promising mice studies, US scientists have revealed today (2 April 2020). More
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote: on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...
On 12/03/2017 Steph wrote:
The photo you have paired with this article is its... on 'Fat shaming' limits...

Experts call for cholera vaccine ban to be lifted

Friday May 15th, 2009

Infectious disease experts called last night for wider use of a life-saving cholera vaccination.

Cholera is a major public health problem in the developing world. In 2007, 177,963 cholera cases and 4,031 deaths were reported to the World Health Organisation (WHO) from 53 countries - 94 per cent of cases in Africa. The true figures are likely to be much higher due to under-reporting.

Despite recommendations from WHO in 2001 for the use of new-generation oral cholera vaccines, no country has yet introduced cholera vaccines into its immunisation programme, with the exception of Vietnam. The oral vaccine used in Vietnam (ORC-Vac) does not comply with WHO guidelines, as it fails to meet quality standards.

Dr Sujit Bhattacharya of the National Institute of Cholera and Enteric Diseases in India, and colleagues, want the WHO to relax the rules. They describe ORC-Vac as "inexpensive, safe, and effective".

To be used outside of Vietnam, the vaccine must be produced in countries where the national regulatory authority has been approved by WHO.

Dr Bhattacharya and colleagues sit on a cholera Policy Forum run by the International Vaccine Institute in Seoul, South Korea. In a statement, published by Science, they say that lifting the ban "is necessary in order to effectively deal with the disease".

"The persistent lethality of the bacterial infection in Africa is proof that new strategies are needed," they state. "Meanwhile, very little has changed in the way aid groups have responded to these outbreaks."

The scope of the problem more than justifies the costs of vaccine implementation, they argue, adding that: "The lack of flexibility to adapt to the [current] circumstances is regrettable; for the people at risk it is a disaster."

Science May 15th 2009

Tags: Africa | Asia | World Health | Gastroenterology | Child Health | Travel

Printer friendly page Printer friendly page